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Abstract
Dendritic cells (DCs) are professional antigen presenting cells that have the dual ability to
stimulate immunity and maintain tolerance. However, the signalling pathways mediating tol-
erogenic DC function in vivo remain largely unknown. The β-catenin pathway has been sug-
gested to promote a regulatory DC phenotype. The aim of this study was to unravel the role
of β-catenin signalling to control DC function in the autoimmune collagen-induced arthritis
model (CIA). Deletion of β-catenin specifically in DCs was achieved by crossing conditional
knockout mice with aCD11c-Cre transgenic mouse line. Bonemarrow-derived DCs
(BMDCs) were generated and used to study the maturation profile of these cells in response
to a TLR2 or TLR4 ligand stimulation. CIA was induced by intra-dermal immunization with
100 μg chicken type II collagen in complete Freund’s adjuvant on days 0 and 21. CIA inci-
dence and severity was monitored macroscopically and by histology. The T cell profile as well
as their cytokine production were analysed by flow cytometry. Lack of β-catenin specifically in
DCs did not affect the spontaneous, TLR2- or TLR4-inducedmaturation and activation of
BMDCs or their cytokine production. Moreover, no effect on the incidence and severity of CIA
was observed in mice lacking β-catenin in CD11c+ cells. A decreased frequency of splenic
CD3+CD8+ T cells and of regulatory T cells (Tregs) (CD4+CD25highFoxP3+), but no changes
in the frequency of splenic Th17 (CCR6+CXCR3-CCR4+), Th2 (CCR6-CXCR3-CCR4+) and
Th1 (CCR6-CXCR3+CCR4-) cells were observed in thesemice under CIA condition. Further-
more, the expression of IL-17A, IL-17F, IL-22, IL-4 or IFNγwas also not affected. Our data
indicate that ablation of β-catenin expression in DCs did not alter the course and severity of
CIA.We conclude that although deletion of β-catenin resulted in a lower frequency of Tregs,
this decrease was not sufficient to aggravate the onset and severity of CIA.
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Introduction
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation
and destruction of cartilage and bone [1, 2]. Although the etiology of RA has yet to be estab-
lished, it is believed that RA results from a breach in immune tolerance. Interactions between
osteoclasts and immune cells, such as T cells primed by activated dendritic cells (DCs), may
contribute to the pathogenesis of RA in humans and murine models [3]. DCs are professional
antigen presenting cells that continuously sample their environment for foreign and self-anti-
gens and play a prominent role balancing immunity and tolerance [4, 5]. The role of DCs in
the initiation of arthritis was demonstrated in mice, where administration of collagen-pulsed
mature DCs is sufficient to induce arthritis. Development of the disease is mediated by both
adaptive and innate effects of DCs, namely priming of autoreactive T cells and induction of
local inflammation via soluble mediators such as TNF [6]. However, owing to their regulatory
function DCs might also have therapeutic potential to treat RA, since administration of semi-
mature or tolerogenic DCs can inhibit collagen-induced arthritis (CIA) [7–9]. In this context,
it is crucial to dissect the molecular pathways that regulate the balance between pro-inflamma-
tory and tolerogenic functions of DCs. It has previously been suggested that β-catenin, an
essential component of the canonical wingless (wnt) pathway and widely expressed in immune
cells including DCs, plays an important role in the switch between a tolerogenic and an immu-
nogenic DC phenotype [10, 11]. Canonic β-catenin signalling represents a receptor-mediated
signal transduction pathway. Binding of a wnt ligand to its receptor frizzled and the co-recep-
tor lipoprotein receptor-related protein (LRP) 5/6 inhibits the activity of the destruction com-
plex targeting β-catenin for degradation. This leads to the cytoplasmic accumulation of β-
catenin and its translocation to the nucleus in order to interact with the T cell-specific tran-
scription factor (TCF) and lymphoid enhancer-binding factor (LEF) that regulate the expres-
sion of wnt target genes [10].
Indeed, there is accumulating evidence that the wnt pathway is involved in promoting a tol-
erogenic DC phenotype. Initially, it was found that disruption of E-cadherin-mediated cell-cell
contacts or mechanical agitation of bone marrow-derived DCs (BMDCs) induces a tolerogenic
DC phenotype in vitro, which is dependent on β-catenin signalling and nuclear translocation
[12]. While activation of β-catenin signalling causes ‘phenotypic’ BMDCmaturation, these
cells fail to produce pro-inflammatory cytokines. Instead, they induce IL-10 production from
naïve T cells in vitro and protection from experimental autoimmune encephalomyelitis (EAE)
in mice [12]. In line, in CD11c-specific β-catenin knockout mice, lamina propria DCs secrete
lower amounts of immunosuppressive cytokines (interleukin-10 (IL-10), and TGF-β) required
for regulatory T cell (Treg) production. Rather, inflammatory T helper type-17 (Th17) cells are
predominantly generated and, consequently, mice are more susceptible to induction of colitis
[13]. Similarly, loss of LRP5/6 β-catenin-mediated signalling in DCs results in increased Th1/
Th17 cell differentiation and a reduced Treg response. This is due to increased and decreased
production of pro- and anti-inflammatory cytokines, respectively, driving exacerbated autoim-
mune neuroinflammation (EAE) [14]. Activation of canonical wnt/β-catenin signalling, by
TLR2-mediated signals or using a β-catenin agonist, results in reduced frequencies of Th1/
Th17 cells, enhanced frequency of Tregs and in the suppression of pro-inflammatory cytokines
production limiting chronic autoimmune inflammation [14, 15].
In this study, we subjected mice lacking β-catenin specifically in CD11c+ DCs to the autoim-
mune CIA model. In addition to monitoring disease incidence and severity, we also examined
the T cell profile during CIA. Our data indicate that specific deletion of β-catenin signalling in
DCs results in lower Treg differentiation without enhancing the severity of CIA.
Ablation of β-Catenin in CD11c+ Cells Did Not Alter CIA
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Material and Methods
Animals and genotyping
All procedures concerning animals were performed with permission of the Committee on the
Ethics of Animal Experiments of the Erasmus MC (DEC nr. 128-11-07 and 128-14-08). All
mice used were maintained on a C57BL/6 genetic background, kept under specific pathogen-
free conditions and provided with food and water ad libitum at the Erasmus MC experimental
animal facility. Eight to 12 week-old mice were used for all experiments. β-catenin conditional
knockout mice (β-cateninFL/FL) [16] were crossed with a CD11c-Cre transgenic mouse line
[17], to specifically remove β-catenin from DCs (β-cateninFL/FL/CD11cCre+/-), mentioned in
the text as β-catDEL. Littermates (β-cateninFL/FL) were used as a control and are mentioned in
the text as control.
Genotyping was performed on chromosomal DNA isolated from toe biopsies. The genotyp-
ing of the loxP-flanked (floxed) β-catenin transgenic animals was performed using the follow-
ing primers: 5’-CACCATGTCCTCTGTCTATCC-3’, 5’-AAGGTAGAGTGATGAAAGTTG
TT-3’ and 5’-TACACTATTGAATCACAGGGACTT-3’ resulting in products of 221 bp for the
wild-type allele, 324 bp for the floxed allele and 500 bp for the deleted allele. The following
primers were used to detect the transgenic Cre expression: 5’-CCGGTCGATGCAACGAGT
GA-3’ and 5’-GGCCCAAATGTTGCTGGATA-3’ generating a 235 bp product.
Bone marrow-derived dendritic cells
BMDCs were prepared by flushing the femurs and tibias of β-catDEL and control mice, filtering
through a 100 μm nylon cell strainer (BD Falcon, Sunnyvale, CA, USA), and depleting red
blood cells by 1 minute incubation at 4°C with ammonium chloride lysis buffer (NH4Cl 0.1555
M, KHCO3 10 mM, Na2EDTA.2H2O 0.1 mM in H2O). Half a million cells/ml were incubated
for 10 days in RPMI-1640 with ultraglutamine 1 medium (Lonza, Basel, Switzerland) contain-
ing 1% of recombinant mouse granulocyte-macrophage colony stimulating factor (GM-CSF),
5% fetal calf serum (FCS), 100 U/ml Penicillin/Streptomycin and 50 μM β-mercaptoethanol.
On day 9 BMDCs were left unstimulated or pulsed for 24 hours with LPS (1 ng/ml; Invitrogen,
San Diego, CA, USA), chicken type II collagen (CII) (50 μg/ml; Chondrex, Redmond, WA,
USA), LPS (1 ng/ml) and CII (50 μg/ml) orMycobacterium tuberculosis (strain H37Ra; Difco)
(25 μg/ml). For CII-specific stimulation, CII was heat inactivated for 10 minutes at 80°C. All
the conditions were performed in triplicates. Data are representative of two-three independent
experiments (n = 6–9 mice/group).
Cytokine ELISA
The levels of IL-6, IL-10, IL-12p70 and IL-23 cytokines were measured in the supernatants of
10-day cultures of BMDCs that were unstimulated or pulsed for 24 hours in the presence of
LPS (1 ng/ml) and CII (50 μg/ml) orMycobacterium tuberculosis (25 μg/ml). Cytokine-specific
ELISAs were used and performed according to the manufacturer’s instructions. Undiluted
samples were used to detect IL-10, IL-12p70 and IL-23; to detect IL-6 samples were diluted
50 times.
Collagen-induced arthritis
Mice were immunized with 100 μg (2 mg/ml) chicken type II collagen (Chondrex, Redmond,
WA, USA) emulsified in an equal volume of complete Freund’s adjuvant (CFA) containing 1
mg/ml heat killedMycobacterium tuberculosis (strain H37Ra; Difco), administered intrader-
mally (i.d.) in the tail base on day 0 and subcutaneously (s.c.) on the mouse back on day 21.
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Mice were killed on day 35. Mice were considered to have arthritis when significant changes in
redness and/or swelling were noted in the digits or in other parts of the paws. Arthritis was
scored visually using the following scale: 0, non-inflamed; 1, mild inflammation; 1.5, marked
inflammation; 2, severe inflammation. Arthritis development was scored macroscopically, with
a maximum possible score of 8 per mouse. Mice with a score of 6 were killed for ethical rea-
sons. Scoring was performed blindly by two independent observers, without knowledge of the
experimental groups [18].
Lymphoid tissue preparation
Spleens were harvested from β-catDEL and control mice and homogenized in ice-cold Hanks’
balanced salt solution (HBSS, Sigma) using 100 μm cell strainers (BD Falcon, Sunnyvale, CA,
USA).
For preparation of DCs, spleens were pre-incubated with 400 units collagenase type IV
(Worthington, Lakewood, NJ, USA) and 0.1 units DNase I (Sigma Aldrich) in RPMI-1640 cul-
ture medium (Lonza, Basel, Switzerland) at 37°C for 40 minutes. Subsequently, 10 μM of
EDTA was added to each sample and incubated for another 5 minutes.
Flow cytometry
For intracellular cytokine staining, splenocytes were stimulated for 4 hours with phorbolmyris-
tate acetate (PMA) (0.05 μg/ml; Sigma-Aldrich) and ionomycin (0.5 μg/ml; Sigma-Aldrich) in
the presence of GolgiStop (BD Bioscience, Sunnyvale, CA, USA). Cells (3x106 per staining)
were stained for 30 minutes at 4°C for extracellular markers and subsequently fixed with 2%
paraformaldehyde (PFA) and permeabilized in 0.5% saponin. Cells were then stained for 40
minutes at 4°C for intracellular markers. For intracellular transcription factors staining a
FoxP3 staining buffer set (eBioscience, San Diego, CA, USA) was used according to the manu-
facturer’s instructions. The following antibodies were used: anti-CD3 (BV785), anti-TCRγδ
(BV605), anti-CCR4 (APC), anti-CCR6 (PE), anti-CXCR3 (PE-Cy7), anti-IL4 (PE-Cy7), anti-
IL17A (BV 421), anti-IL22 (A647), anti-IL10 (A488), anti-TNFα (PerCP-Cy5.5), anti-MHCII
(A647), anti-CD80 (PerCP-Cy5.5) from Biolegend; anti-CD4 (PE-Cy7), anti-CD8α (PE-Cy5;
APC-H7), anti-CD25 (PerCP-Cy5.5), anti-CD62L (APC-Cy7), anti-NK1.1 (A700), anti-
CXCR5 (FITC), anti-IL17A (A647), anti-IL12 (p40/p70) (PE), anti-PD-L2 (PE) from BD Phar-
mingen; anti-IL17F (PE), FoxP3 (PE-Cy7), anti-CD11c (PE-Cy5.5), anti-MHCII (A700) from
eBioscience; anti-CD4 (V500), anti-CD11c (BV786), anti-IFNγ (PE-CF594), anti-IL6 (V450),
anti-CD40 (BV421), anti-CD86 (BV605), anti-PD-1 (BV421, PE-CF594) from BD Horizon;
and anti-β-catenin (A647) from Cell Signalling. Samples were acquired on a BD LSR Fortessa
(BD Biosciences, San Jose, CA, USA). Flow cytometric results were analysed using FlowJo, ver-
sion 7.6.5.
Histological analysis
Three arthritic knees from control and 3 from β-catDEL mice were fixed for 4 days in 10% for-
malin, decalcified in 5% formic acid and embedded in paraffin. Tissue sections (7 μm) were
made and stained with hematoxylin and eosin. Sections were assessed for joint inflammation
(infiltrate and exudate) and bone and cartilage erosions [19]. The severity of inflammation was
scored on a scale of 0–3 (0 = no cells, 1 = mild cellularity, 2 = moderate cellularity, and 3 =maxi-
mal cellularity). The severity of bone and cartilage damage was scored separately based on
bone and cartilage erosions score using a scale from 0–3 (0 = no erosion, 1 = mild erosion,
2 = moderate erosion, and 3 = maximal erosion) and on chondrocyte death (0 = no cell death,
1 = mild cell death, 2 = moderate cell death, and 3 = maximal cell death). Histopathological
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changes in the knee joints were scored in the patella/femur region on three semiserial sections
of the joint, spaced 70 μm apart.
Measurement of collagen-specific antibodies
For the measurement of CII-specific antibodies in serum, 96-well microtiter plates were coated
overnight with 1 μg/ml chicken or mouse CII (Chondrex, Redmond, WA, USA). Serum sam-
ples and reference samples were diluted serially and incubated in the plates for 3 hours at room
temperature. Secondary antibodies (goat-anti-mouse biotinylated IgG total, IgG1, and IgG2c;
Southern Biotechnology) were incubated for 1 hour at room temperature. Conjugation was
performed with poly-HRP-streptavidin for 30 minutes (Sanquin, Amsterdam, The Nether-
lands). Substrate development was done with 3,3',5,5'-Tetramethylbenzidine (TMB) (KPL,
Maryland, USA). Plates were developed for approximately 15 minutes and the reaction was
stopped with 0.5 M H2SO4. Optical density was measured at 450 nm.
Quantitative real-time PCR analysis
RNA was extracted from synovium and cortex from 6 control and 6 β-catDEL naïve mice using
TRIzol1 reagent (Life technologies) according to manufacturer’s instructions and after the
final precipitation dissolved in RNase-free water. Total RNA (0.5 μg) was reverse transcribed
into first-strand cDNA with Superscript II reverse transcriptase (Invitrogen) and 50 ng random
primers during 50 minutes at 50°C in a total volume of 20 μl. From all samples, a 1:20 dilution
was made and used for Quantitative real-time PCR (qPCR) analysis.
qPCR primers were designed with ProbeFinder software and probes were chosen from the
universal probe library (Roche Applied Science, Indianapolis, IN). qPCR was performed using
the ViiA 7 real-time PCR system (Life Technologies) and analysed using ViiA™ 7 software (Life
Technologies). The transcription values were normalized against Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) transcription. Primers and probes used: GAPDH forward 5’-AGCT
TGTCATCAACGGGAAG-‘3, GAPDH reverse 5’-TTTGATGTTAGTGGGGTCTCG-‘3,
probe 9; Wnt2b forward 5’-CCGGGACCACACTGTCTTT-‘3, Wnt2b reverse 5’-GCTGACGA
GATAGCATAGACGA-‘3, probe 16; Wnt3 forward 5’-CTCGCTGGCTACCCAATTT-‘3,
Wnt3 reverse 5’-GAGGCCAGAGATGTGTACTGC-‘3, probe 81; Wnt5a forward 5’-ACGCTT
CGCTTGAATTCCT-‘3, Wnt5a reverse 5’-CCCGGGCTTAATATTCCAA-‘3, probe 55;
Wnt5b forward 5’-AGCACCGTGGACAACACAT-‘3, Wnt5b reverse 5’-AAGGCAGTCTCTC
GGCTACC-‘3, probe 53; Wnt7a forward 5’-CGCTGGGAGAGCGTACTG-‘3, Wnt7a reverse
5’- CGATAATCGCATAGGTGAAGG-‘3, probe 12; Wnt8a forward 5’-ACTGCGGCTGTGA
CGAGT-‘3, Wnt8a reverse 5’-CCCGAACTCCACGTTGTC-‘3, probe 75; Wnt8b forward 5’-
GTGGACTTCGAAGCGCTAA-‘3, Wnt8b reverse 5’-GGGTGTACATAACCCCAGCA-‘3,
probe 94; Wnt9a forward 5’-CGAGTGGACTTCCACAACAA-‘3, Wnt9a reverse 5’- GGCATT
TGCAAGTGGTTTC-‘3, probe 19.
Statistical analysis
Differences between groups were tested with the Mann-Whitney U test, unless noted otherwise.
Data were analysed using Graph-Pad Prism, version 5.01 (Graphpad Software Inc., La Jolla, CA).
P values less than 0.05 were considered significant ( p< 0.05;  p< 0.01;  p< 0.001). Error
bars are presented as standard error of the mean (SEM).
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Results and Discussion
Ablation of β-catenin specifically in CD11c+ cells did not influence the
maturation and activation of BMDCs in response to TLR2 or TLR4
activation
BMDCs are a convenient source of large amounts of DCs and express high levels of β-catenin.
Thus, we investigated the efficiency of Cre-mediated recombination of the β-catenin gene in
BMDCs generated from β-catDEL mice by studying the level of β-catenin protein expression
using flow cytometry. We observed that the mean fluorescence intensity (MFI) of β-catenin
was significantly decreased by 88% in immature β-catDEL as compared to control BMDCs (Fig
1A–1D). A similar decrease was observed in DCs isolated from lungs and skin of β-catDEL mice
(Ober-Blöbaum, J.L. and Clausen, B.E. unpublished data). Next, we asked whether BMDC acti-
vation/maturation alters β-catenin expression. Therefore, we measured the level of β-catenin in
BMDCs left untreated or pulsed for 24 hours with CII (Fig 1A and 1B), a TLR4 ligand (LPS)
(Fig 1A and 1B), a combination of both (LPS and CII) (Fig 1A and 1B) or withM. tuberculosis
(MTB) (Fig 1C and 1D). In the control, stimulation with LPS or with MTB, but not CII,
resulted in an increase in the levels of β-catenin compared to unstimulated cells (Fig 1A, 1B, 1C
and 1D). As expected, in the β-catDEL group, LPS (Fig 1A and 1B) or MTB (Fig 1C and 1D)
stimulation both failed to trigger any expression of β-catenin. These data indicate efficient Cre-
mediated deletion of β-catenin in immature and mature β-catDEL BMDCs and that TLR2- or
TLR4-induced maturation of BMDCs by MTB or LPS respectively leads to an upregulation of
β-catenin, which is in line with previous studies [15].
Since Jiang et al. reported that the phenotypic maturation of cluster disrupted BMDCs was
mediated by β-catenin translocation to the nucleus [12], we compared the expression levels of
the co-stimulatory molecules CD80, CD86 and CD40 and of the co-inhibitory molecule PD-L2
on the surface of β-catDEL and control BMDCs. Treatment of BMDCs with LPS or LPS + CII
(Fig 1A and 1B) or MTB (Fig 1C and 1D) induced high expression of CD80, CD86 and CD40
maturation markers, while addition of CII antigen alone elicited no effects on these molecules.
Intriguingly, the phenotypic maturation of control and β-catDEL BMDCs was similar (Fig 1A,
1B, 1C and 1D). These results indicate that in contrast to the observation made by Jiang et al.,
where overexpression of β-catenin resulted in phenotypic DC maturation, the deletion of β-
catenin does not impair BMDCmaturation in response to a TLR2 or a TLR4 ligand [12]. Our
data is consistent with previous study performed by van der Lugt et al. where it was demon-
strated that BMDCs infected with shRNAs against β-catenin responded normally to LPS stimu-
lation [20]. The same authors showed also that BMDCs depleted from β-catenin using the
same strategy do not respond to mechanical stimulation.
In line with the unaltered immature phenotype of untreated β-catDEL BMDCs, we did not
observe any differences in the expression of co-stimulatory and co-inhibitory molecules on
splenic CD11c+ DCs from naïve β-catDEL and control mice (Fig 2A and 2B, left panel).
Manicassamy et al. demonstrated that DCs isolated from the lamina propria of β-catDEL
mice expressed higher mRNA levels of the pro-inflammatory cytokines IL-23 and IL-6 and
lower mRNA levels of the anti-inflammatory cytokines IL-10 [13]. Therefore, we examined
whether the lack of β-catenin in BMDCs changed the expression of signature cytokines for T
helper cell skewing. The levels of IL-6, IL-10, IL-12p70 and IL-23 were measured in the super-
natant of cells left unstimulated or pulsed with LPS and CII. Except for the anti-inflammatory
IL-10, unstimulated cells fail to produce any of the pro-inflammatory cytokines tested (Fig 1E).
As expected, stimulation with LPS and CII resulted in a marked induction of IL-6, IL-12p70
and IL-23 but not of IL-10 (Fig 1E). No differences were observed in cytokine levels between
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Fig 1. Ablation of β-catenin did not influence the maturation and activation of BMDCs. BMDCs were cultured in the presence of GM-CSF for 10 days,
and either left unstimulated (spontaneous maturation), treated with LPS (1 ng/ml), or (chicken) CII (50 μg/ml) or LPS and CII (50 μg/ml; 1 ng/ml respectively)
(A, B) or withMycobacterium tuberculosis (MTB, 25 μg/ml) (C, D). Twenty-four hours after stimulation, BMDCs were collected and analysed by flow
cytometry for their maturation status. The levels of β-catenin, co-stimulatory molecules (CD40, CD80, CD86), the co-inhibitory molecule PD-L2 were
measured in CD11c+ BMDCs derived from control and β-catDEL mice. Levels of cytokines associated with tolerance (IL-10) and T cell skewing (IL-23,
IL12p70 and IL-6) were determined by ELISA of the supernatants of control and β-catDEL BMDCs, left unstimulated or pulsed with CII and LPS (E) Or of the
supernatants from BMDCs, left unstimulated or stimulated with MTB (F). All culture conditions were performed in triplicates. Data are representative of two to
three independent experiments (n = 6–9 mice/group). Data on (B and D) were analysed by one-way ANOVA followed by a Bonferroni post-test and data on
(E and F) was analysed by Mann-Whitney U test. Data are presented as mean ± SEM. *p< 0.05; **p<0.01; ***p<0.001. N.d. Not detectable.
doi:10.1371/journal.pone.0142972.g001
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control and β-catDEL BMDCs in any of the conditions tested (unstimulated; LPS and CII)
(Fig 1E).
Our data obtained using BMDCs revealed that deletion of β-catenin did not affect the spon-
taneous or TLR4-induced DC maturation and cytokine production in vitro. The specific LPS-
mediated signalling cascade is initiated by the interaction between LPS and TLR4, adaptor pro-
teins, including myeloid differentiation protein 88 (MyD88), tumour necrosis factor receptor-
associated factor 6 (TRAF6), and MyD88 adapter-like (MAL), are subsequently recruited β-
catenin. Finally, downstream signalling pathways such as MAPKs and NF-kB are activated
[21]. Thus, our data suggest that LPS-mediated signalling and LPS-mediated maturation is
independent of β-catenin. By contrast, others demonstrated that β-catenin is necessary for
BMDC maturation and tolerogenic DC activation by mechanical stimulation [12]. These find-
ings suggested that the release of the β-catenin pool associate with E-cadherin, at the adherens
junctions, together with disruption of cell-cell contact might boost the levels of the free-β-cate-
nin in the cytosol and consequent increase in wnt signalling resulting in maturation of the
BMDCs. Moreover, these two processes, LPS and mechanic stimulation, seem to be indepen-
dent once treatment of BMDCs with anti-E-cadherin did not inhibit maturation induced by
LPS and DCs lacking Tlr4, that cannot respond to LPS, exhibited robust maturation after
mechanical stimulation [12].
Recently, it has been shown that stimulation of BMDCs lacking LRP5/6, and consequently
β-catenin signalling, withM. tuberculosis resulted in an increase of IL-6, TNFα, IL-12 and a
reduction of IL-10 [14]. We stimulated BMDCs withM. tuberculosis and in contrast to the
observations performed by Suryawanshi et al. we did not observed differences in the levels of
IL-6, IL-10 and IL-12p70 between control and β-catDEL BMDCs (Fig 1F). Suggesting that
upstream signals of the wnt signalling are important to control the expression of the differences
cytokines, rather than β-catenin alone.
Also, other studies demonstrated that augmented β-catenin signalling leads to enhanced
phenotypic DC maturation without production or secretion of immunostimulatory cytokines
[12, 15, 20, 22]. Moreover, treatment of immature DCs with a GSK-3β inhibitor, which led to
an increase in β-catenin signalling, resulted in an increase in the expression of CD80, CD86
and CD40 on the cell surface, in vitro [23].
In summary, deletion of β-catenin from BMDCs did not influence the expression levels of
co-stimulatory molecules and cytokine production.
Lack of β-catenin specifically in CD11c+ DCs did not affect T cell
homeostasis in the steady state
To determine whether ablation of β-catenin inDCs has an indirect effect on the T cell compart-
ment in naïve animals, we studied the homeostasis of CD8+, TCRγδ+, total CD4+ and NK1.1+
Fig 2. Deletion of β-catenin in DCs during CIA resulted in a reduction of the co-stimulatory molecules
CD80 and MHC-II in CIA.Representative histogram of CD40, CD80, CD86, MHC-II and PD-L2 expression
by CD11c+ DCs isolated from the spleen under steady-state condition (left column) and during CIA (right
column) from control and β-catDEL mice (A). Spleen from CIA mice were collected at day 35 after initial
immunization. Bar diagrams show the quantification of the MFI relative to the expression of costimulatory
molecules (B). No differences in the expression of costimulatory molecules between naïve control and β-
catDEL naïve mice were observed (CD40: p = 0.132; CD80: p = 0.289;CD86: p = 0.132;MHC-II: p = 0.575;
PD-L2: p = 0.589; n = 6 mice per group). In the CIA group (n = 10 mice per group), differences in CD80
(p = 0.028) and MHC-II (p = 0.009) were found between control and β-catDEL mice. No differences were found
in the expression of CD40 (p = 0.121), CD86 (p = 0.082) and PD-L2 (p = 0.325) in the CIA group. Data are
presented as mean + SEM. Asterisks indicate a significant difference compared with the control (Mann-
WhitneyU test). *p< 0.05; **p<0.01.
doi:10.1371/journal.pone.0142972.g002
Ablation of β-Catenin in CD11c+ Cells Did Not Alter CIA
PLOS ONE | DOI:10.1371/journal.pone.0142972 November 20, 2015 9 / 23
(natural killer, NK) T cells. An increase in the frequency of total CD3+CD4+ T cells was
observed in β-catDEL as compared to control mice (control = 48.08% ± 0.611 versus β-catDEL =
51.30% ± 0.942, p = 0.0304). No changes in the frequencies of CD3+CD8+, CD3+TCRγδ+ and
NK T cells were detected (Fig 3). The percentage of T follicular helper (Tfh) cells (CD3+CD4+-
CD62L-CXCR5+PD-1+) was comparable between the two groups (Fig 3). To further assess the
frequencies of different Th cell subsets, such as Th1, Th2, Th17 and Th17.1 (also called non-
classic Th1 cells having characteristics of both Th17 and Th1 cells), we developed a flow
Fig 3. Ablation of β-catenin in DCs resulted in elevated total CD4+ T-cell numbers under steady state
condition. The left panels depict representative FACS plots of CD8+, TCRγδ+, CD4+, CD4+CCR6- and
CD4+CCR6+, Th17 or Th17.1 and Th2 or Th1 T cells isolated from the spleens of control and β-catDEL mice
under steady state condition. The right panels illustrate the quantification of the percentages of CD8+,
TCRγδ+, CD4+, Tfh (CXCR5+PD-1+), CD4+CCR6+ and CD4+CCR6- T cells, expressed in frequency of total T
cells (CD3+); the frequency of NK T cells (NK1.1+) is expressed in percentage of CD3- cells. The percentages
of Th cells were expressed in frequency of effector T-cells (CD3+CD4+CD62L-). N = 6 mice per group. Data
are presented as mean + SEM. Asterisks indicate a significant difference compared with the control (Mann-
WhitneyU test). *p< 0.05.
doi:10.1371/journal.pone.0142972.g003
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cytometry gating strategy to identify these T cell populations based on their unique combina-
tion of chemokine receptors (CCR6, CCR4 and CXCR3) present on their cell surface (S1 Fig).
First, CD4+ T cells were divided into two populations according to their CCR6 expression. In
the CCR6+ compartment, Th17 cells were defined as CCR4+CXCR3- and Th17.1 as
CCR4-CXCR3+ cells. In the CCR6- compartment, Th2 cells were defined as CCR4+CXCR3-
and Th1 as CCR4-CXCR3+ cells (S1 Fig) [24, 25]. No differences were observed between the
percentages of CD4+CD62L-CCR6- (control = 7.320% ± 1.1060 versus β-catDEL = 7.043% ±
0.5201, p = 0.5887) and CD4+CD62L-CCR6+ (control = 0.7185% ± 0.5215 versus β-catDEL =
0.5203% ± 0.1027, p = 0.1797) T cell populations in spleens of naïve β-catDEL and control mice
(Fig 3). The percentage of Th17.1 cells was reduced in the β-catDEL compared to the control
group (control = 0.9088% ± 0.1058 versus β-catDEL = 0.5648% ± 0.4809, expressed in percent-
age of effector T cells, p = 0.0411) (Fig 3). No further changes were detected for any other Th
cell subsets within both the CCR6+ and CCR6- compartment (Fig 3), including similar levels of
splenic Tregs (CD4+CD25highFoxP3+) between the β-catDEL and control group (con-
trol = 13.41% ± 4.624 versus β-catDEL = 13.31% ± 2.188, expressed in percentage of effector T
cells, p = 0.9372) (Fig 4A, left panel).
Though we did not observe changes in the homeostasis of the different T cell subsets in the
steady state, their cytokine production could be affected during inflammation. Therefore, we
studied whether deletion of β-catenin in DCs influenced the cytokine production by the differ-
ent T cell subsets. Splenocytes were isolated from naïve β-catDEL and control mice and stimu-
lated in vitro with phorbolmyristate acetate (PMA) and ionomycin for 4 hours. We did not
find differences in the production of IFNγ, IL-4, IL-10, IL-17A, IL-17F and IL-22 by CD4+ T cells
(Fig 5, left panel) as well as in the production of IFNγ by CD3+CD8+ and CD3-NK1.1+ T cells
(data not shown). Although, we observed a decrease in the Th17.1 subpopulation in β-catDEL
mice, we did not observe a decrease in the levels of the IL-17 and IFNγ cytokines secreted by
Th17.1 cells. One explanation could be that the cytokine levels were analysed in the bulk CD4+ T
cells and not specifically in each T cell subset. Since once the Th17.1 cells are approximately
1.50–2.5% of all the CD4+ T cells we might not be able to distinguish the contribution of this par-
ticular population in the production of these cytokines that are also produced by Th1 (IFNγ) and
Th17 (IL-17).
In summary, deletion of β-catenin in CD11c+ DCs did not indirectly affect splenic T cell
populations under steady state conditions, which is in line with previous studies demonstrating
that lack of β-catenin specifically in DCs did not change the percentages of splenic Tregs, Th1
or Th17 cells [13, 15]. In contrast, in the intestine ablation of β-catenin in CD11c+ cells resulted
in a decrease of Tregs and an increase of Th17 and Th1 cells [13]. Manicassamy et al. suggested
that the difference in Treg frequencies observed between tissues, i.e. the spleen and intestine,
might be due to the expression levels of wnt ligands and frizzled receptors by CD11c+ cells.
They reported that CD11c+ cells isolated from the lamina propria of control mice expressed
higher amounts ofWisp1 and Axin1mRNA than CD11c+ cells isolated from the spleen. This
resulted in higher activation of wnt signalling in intestinal CD11c+ cells programming them to
induce Tregs [13].
Deletion of β-catenin in CD11c+ cells did not alter the course nor the
severity of autoimmune collagen-induced arthritis (CIA)
Although the lack of β-catenin in CD11c+ cells did not significantly affect the immunological
steady state, it may exacerbate a DC/T cell-mediated autoimmune disease model. Therefore,
we subjected β-catDEL and control mice to autoimmune CIA. Arthritis induction could be
observed in mice as early as 17 days after the first immunization. The CIA incidence in our
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Fig 4. Ablation of β-catenin in DCs downregulates Tregs during CIA but not under steady state
condition. Representative FACS plots of Tregs (CD4+CD62L-CD25highFoxP3+) isolated from splenocytes
from control and β-catDEL mice in the steady state and subjected to CIA (35 days after the first immunization)
(A). Bar diagrams depicting the frequency of Tregs, expressed as the percentage of effector T cells
(CD4+CD62L-), in control and β-catDEL groups in the steady state (n = 6 mice per group, left) and in mice
subjected to CIA (n = 10 mice per group, right) (B). While in the steady state no differences in the percentage
of Tregs were found between the two groups (control = 13.41% ± 4.624 versus β-catDEL = 13.31% ± 2.188,
p = 0.9372), in the CIA mice we observed a reduction of 20% in the β-catDEL compared to the control group
(control = 12.93% ± 0.5691 versus β-catDEL = 10.21% ± 0.9003, p = 0.0435). Data are presented as mean
+ SEM. Asterisks indicate a significant difference compared with the control (Mann-Whitney U test). *p< 0.05.
doi:10.1371/journal.pone.0142972.g004
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Fig 5. β-catenin deletion in DCs did not affect the cytokine production by CD4+ T cells in the steady state or during CIA. Representative FACS plots
illustrating the pro-inflammatory cytokines IFNγ, IL-4, IL-17A and anti-inflammatory IL-10 produced by CD4+ T cells isolated from spleens of steady-state (left
panel, n = 8 mice per group) and CIA (right panel, n = 10 mice per group) mice, on day 35 after the first immunization. Cells were stimulated for 4 hours with
phorbolmyristate acetate (PMA) (0.05 μg/ml) and ionomycin (0.5 μg/ml) in the presence of GolgiStop. The frequencies of the different cytokine-secreting Th
cells were similar in the β-catDEL and control groups in both conditions. Data are presented as mean ± SEM.
doi:10.1371/journal.pone.0142972.g005
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experiments (56–60%) is in line with previous reports using mice on a C57/BL6 genetic back-
ground [26–28] (Fig 6A). The overall CIA incidence, on day 34 after the first immunization,
was very similar between the control (arthritis incidence = 56.5%, n = 46) and β-catDEL (arthri-
tis incidence = 60.4%, n = 48) mice (Fig 6A). Moreover, the onset and progression of the dis-
ease was also similar in both groups (Fig 6A).
In mice that developed CIA, the disease severity reached an average score of 3.5 ± 0.5 in the
control (n = 26) and 2.6 ± 0.4 in the β-catDEL (n = 29) group on day 34 (p = 0.3765) (Fig 6B).
Statistical differences between the two groups were not reached at any of the time points ana-
lysed (day 27, p = 0.8560; day 29, p = 0.5304; day 31, p = 0.2539). Histopathological analysis of
knee joints of control and β-catDEL mice showed a similar extent of synovial inflammation with
high numbers of cells infiltrating into the synovial tissue (control = 1.123 ± 0.228 versus β-cat-
DEL = 1.087 ± 0.007, p = 1.000) (Fig 6C–6F, arrowheads). Mild destruction of cartilage in the
patellar and femoral regions, measured as the degree of chondrocyte death (con-
trol = 1.116 ± 0.089 versus β-catDEL = 0.650 ± 0.143, p = 0.100) (Fig 6C–6F, arrows) and carti-
lage surface erosion (control = 1.610 ± 0.1268 versus β-catDEL = 0.980 ± 0.175, p = 0.100) (Fig
6C–6F, asterisks), was observed in both groups. Bone erosion was detected sporadically with-
out differences between both groups.
In summary, deficiency of β-catenin in DCs did not accelerate the onset, progression or
exacerbate the severity of CIA.
The impact of β-catenin deficiency in DCs was studied before in a mouse model of inflam-
matory bowel disease (IBD) induced by dextran sodium sulphate (DSS), and for multiple scle-
rosis, the experimental autoimmune encephalomyelitis (EAE) [13–15]. In both models, mice
lacking β-catenin in CD11c+ cells exhibited an exacerbation of the disease severity and an
increase in local inflammation [13–15]. On the other hand, immunization with myelin oligo-
dendrocyte glycoprotein peptide-pulsed DCs that were matured by mechanical disruption of
E-cadherin-mediated cell adhesion leading to the activation of β-catenin signalling, could pro-
tect recipient mice against the neuropathology associated with EAE [12]. Moreover, pharmaco-
logical activation of canonical wnt/β-catenin signalling delayed EAE onset and diminished
central nervous system pathology [14]. In contrast, data from this study indicate that the β-
catenin pathway in DCs is not critical in controlling autoimmune arthritis. In order to exclude
that the absence of a phenotype in our CIA model is due to a difference in the microbiota and/
or housing conditions and/or in the genetic background we submitted our β-catDEL to a DSS-
induced colitis model. Indeed our β-catDEL mice were more susceptible to colitis than the con-
trol animals (data not shown) which is in line with published data [13]. Together, these data
suggest that the differences in phenotype in β-catDEL mice are indeed relative to the disease
model.
Lack of β-catenin did not influence the development of auto-antibodies
in CIA
Both T cell and humoral immune responses have been described to be essential in the patho-
genesis of CIA. Mice immunized with CII developed elevated serum IgG1 and IgG2a/2c anti-
bodies against CII (Fig 7), which represent a read out of systemic immune activation after
immunization with chicken CII in CFA. Due to a not yet fully elucidated mechanism this
immune activation will lead to specific (auto-)antibody induction against autologous mouse
CII, probably directed at conserved amino acid sequences of CII, that triggers the autoimmune
process. Therefore, we determined the serum levels of the specific immunoglobulins IgG1 and
IgG2a/2c against both the heterologous (chicken) and autologous (mouse) CII, in order to
accurately correlate auto-antibody levels with the development and severity of autoimmune
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arthritis. In particular, IgG2c can be found in C67BL/6 mice with CIA and is considered to
play an important role in the pathogenesis of autoimmune arthritis via complement activation
Fig 6. Deletion of β-catenin in DCs did not alter the onset and severity of autoimmune CIA. Arthritis induction could be observed in mice as early as 17
days after immunization (A). There was no difference in the CIA incidence between the control (arthritis incidence = 56.5%, n = 46) and β-catDEL (arthritis
incidence = 60.4%, n = 48) group (A). In addition, no difference in the disease severity was observed between the control (n = 26) and β-catDEL group (n = 29)
(B). The disease severity reached a maximal average score of 3.5 ± 0.5 in the control and 2.6 ± 0.4 in the β-catDEL group on day 34 (p = 0.3765) (B).
Representative histological images of the knees of CIA control (C and D) and β-catDEL (E and F) mice collected on day 35 after the first immunization. The
tissue sections were stained with hematoxylin and eosin. Scale bar: 50 μm. JS = joint space; P = patella; S = synovial membrane; F = femur; C = cartilage.
doi:10.1371/journal.pone.0142972.g006
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and immune complex mediated Fcγ receptor activation [28–30]. Circulating levels of CII-spe-
cific IgG1, IgG2c and total IgG were not detectable in sera of mice before immunization (data
not shown). The Cll-specific antibody response of mice from both groups on days 14 and 35
after the first immunization was similar in magnitude and IgG subclass distribution (IgG1,
IgG2c, and total IgG) (Fig 7). These data indicate that deletion of β-catenin in DCs did not
affect the production of CII-specific antibodies by B-cells during CIA.
Deletion of β-catenin in DCs resulted in decreased Tregs in CIA
Next, we investigated the effect of β-catenin ablation specifically in DCs on the T cell profile in
the autoimmune CIA model. Splenocytes were isolated from CIA mice on day 35 after the first
immunization. Spleens from β-catDEL CIA mice displayed similar percentages of TCRγδ+, total
CD4+ and NK1.1+ NK T cells as compared to controls, whereas a small decrease of CD3+CD8+
T cells (control = 32.94% ± 0.450 versus β-catDEL = 30.26% ± 0.544, p = 0.0036, n = 10 mice per
group) was noted (Fig 8). The percentage of Tfh cells between the two groups was comparable
(Fig 8). We further assessed the frequencies of the different Th cell subsets, namely Th1, Th2,
Th17 and Th17.1, as identified by differential expression of the chemokine receptors CCR6,
CCR4 and CXCR3. The percentages of all these subsets were similar between both groups (Fig
8). Subsequently, we analysed whether the levels of Tregs were affected by deletion of β-catenin
in DCs during CIA and observed a decrease of about 20% in the percentage of splenic Tregs
Fig 7. Serum levels of CII-specific antibodies in CIAmice. Enzyme-linked immunosorbent assay (ELISA) of chicken and mouse CII-specific IgG1, IgG2c,
or total IgG in the serum of β-catDEL mice and control littermates at days 14 and 35 after initial immunization (n = 10 mice per group). Data are presented as
mean + SEM.
doi:10.1371/journal.pone.0142972.g007
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(CD4+CD25highFoxP3+) in the β-catDEL group (control = 12.93% ± 0.5691 versus β-catDEL =
10.21% ± 0.9003, expressed in percentage of effector T-cells, p = 0.0435) (Fig 4A, right panel). Of
note, this differs frommice under steady state conditions where the percentages of Tregs between
β-catDEL and control animals were similar (Fig 4B). Kelchtermans et al. demonstrated that Tregs
(CD4+CD25+ cells) play an important role in CIA, and that depletion of CD25+ cells after
Fig 8. DC-specific ablation of β-catenin modulated the percentage of CD4+ T cell subsets in CIAmice.
Left panels: Representative FACS plots depicting CD8+, TCRγδ+, CD4+, CD4+ CCR6- and CD4+ CCR6+,
Th17 or Th17.1 and Th2 or Th1 T cells isolated from the spleens of CIA control and β-catDEL mice at day 35
after initial immunization. Right panels: Quantification of the percentages of CD8+, TCRγδ+, CD4+, Tfh
(CXCR5+PD-1+) and CD4+CCR6+ and CD4+CCR6- T cells, expressed as frequency of total T cells (CD3+);
NK T cells (NK1.1+) are plotted as percentage of CD3- cells. The percentages of Th cells were expressed as
frequency of effector T cells (CD3+CD4+CD62L-). N = 10 mice per group. Data are presented as
mean ± SEM. Asterisks indicate a significant difference compared with the control (Mann-Whitney U test).
*p< 0.05; **p<0.01.
doi:10.1371/journal.pone.0142972.g008
Ablation of β-Catenin in CD11c+ Cells Did Not Alter CIA
PLOS ONE | DOI:10.1371/journal.pone.0142972 November 20, 2015 17 / 23
immunisation with CII significantly accelerated the onset of arthritis and increased the severity
of CIA [29]. In agreement, others reported that Treg cell transfer markedly slowed CIA progres-
sion [30] and, more recently that induced Tregs are able to suppress the development of CIA
[31].
The 20% reduction of Tregs in the absence of accelerated disease observed in this study sug-
gests that there may be other cell types with regulatory capacity that could compensate for a
decrease in Tregs. One candidate are CD4+FoxP3- type 1 regulatory T (Tr1) cells that secrete IL-
10. However, IL-10 production by CD4+ T cells was similar between β-catDEL and control mice
(Fig 5, right panel), indicating that Tr1 cells do not compensate for the loss of Tregs in CIA.
Other candidates are endogenous IL-10 secreting B cells (so called regulatory B cells). Carter el al.
described that mice lacking regulatory B cells developed exacerbated CIA associated with a
marked increase in inflammatory Th1 and Th17 cells [32]. We did not analyse the levels of regu-
latory B cells and further studies are needed to examine whether this cell type compensates for
the reduction of Tregs, explaining why we did not observe exacerbated CIA in the β-catDEL mice.
Previous studies demonstrated that DC-specific deletion of β-catenin lowers Treg frequen-
cies in tumours [33] and in the intestine during IBD, but not in the spleen nor in the central
nervous system during EAE [13–15]. TLR2-mediated activation of the β-catenin pathway
resulted in an increase in the levels of Tregs in spleens of wild type, which was attenuated in β-
catDEL mice [15].
In summary, ablation of β-catenin specifically in DCs resulted in a decrease in CD3+CD8+ T
cells and Tregs in the autoimmune CIA model.
Deletion of β-catenin in DCs did not influence cytokine secretion of CD4+
T cells in CIA
We evaluated if deletion of β-catenin in DCs affected the cytokine production of CD4+ T cells.
Therefore, the levels of pro-inflammatory cytokines IFNγ, IL-4, IL-17A, IL-17F and IL-22 and
anti-inflammatory IL-10 were measured by flow cytometry in splenocytes of CIA mice on day
35 after the first immunization. The levels of the different cytokines, produced by CD4+ T cells,
were similar between the control and β-catDEL group (Fig 5, right panel). Also, no differences
in the production of IFNγ by CD8+ T cells (control = 2.896% ± 0.400 versus β-catDEL = 4.027%
± 1.085, p = 0.9698) and NK1.1+ T cells (control = 11.2% ± 1.774 versus β-catDEL = 7.83% ±
1.521, p = 0.2729) were found between the two groups. Others have shown that CD4+ T cells
isolated from the intestines of β-catDEL mice, subjected to IBD, showed elevated mRNA expres-
sion of the Th17 cell-associated cytokines IL-17 and IL-21 and of the Th1 cytokine IFNγ as
compared to control mice [13]. Similarly, ablation of β-catenin signalling resulted in an
increase in the percentage of IFNγ+, IL-17+ and TNFα+ CD4+ T cells in the central nervous sys-
tem in an EAE model [14].
In summary, deletion of β-catenin in DCs did not influence cytokine secretion (IFNγ, IL-4,
IL-17A, IL-17F, IL-22 IL-10) of CD4+ T cells in CIA.
Deletion of β-catenin in DCs resulted in a reduction of the co-stimulatory
molecules CD80 and MHC-II in CIA
We also studied the effect of β-catenin deletion in DCs on the levels of co-stimulatory (CD40,
CD80, CD86, MHC-II) and co-inhibitory (PD-L2) molecules on splenic CD11c+ cells in the
context of CIA. In contrast to their comparable expression under steady state conditions, in
CIA mice the levels of CD80 (p = 0.0282) and MHC-II (p = 0.0089) were significantly reduced
in β-catDEL mice (Fig 2). No differences were found in the levels of CD40, CD86 and PD-L2
(Fig 2, right panel). A recent study demonstrated that CD11c+ DCs from β-catDEL mice isolated
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from tumour-draining lymph nodes expressed enhanced levels of the activation markers CD80
and CD86, and less of the co-inhibitory molecules PD-L1 and PD-L2 [33, 34]. However, no dif-
ferences were found in the amount of MHC-II, CD40, CD80 and CD86 on DCs lacking LRP5/
6 as compared to wild type cells upon complete Freund’s adjuvant immunization in vivo [14].
In contrast, Jiang et al. showed that overexpression of β-catenin increased the percentage of
CD86hi DCs [12].
The discrepancy of these data suggests that the β-catenin pathway regulates the activation of
DCs in a context-dependent manner.
Differential expression of wnt ligands in synovium and cortex during
steady state
The differences observed in the disease models EAE, IBD and CIA might be explained by the
levels of wnt ligand expression in the respective target tissues, such as brain, lamina propria
and joints (bone/cartilage/synovium), as well as in the tissue-resident DCs. Suryawanshi et al.
observed elevatedWnt3a andWnt5a expression in the draining lymph node during disease
induction and in the central nervous system during the EAE effector phase [14]. Others
reported that CD11c+ cells isolated from the lamina propria expressed higher amounts of the
wnt target genesWisp1 and Axin1 than CD11c+ cells isolated from the spleen [35].
We studied the presence of several wnt ligands, namely: wnt2b, wnt3, wnt5a, wnt5b, wnt7a,
wnt8a, wnt8b and wnt9a in the synovial tissue of naïve mice. From all the wnt ligands analysed
in the synovium, we only detected expression of wnt2b, wnt5a, wnt5b and wnt9a (Fig 9A). In
the synovial tissue, no differences were found between the expression of wnt2b, wnt5a, wnt5b
and wnt9a between control and β-catDEL mice (Fig 9A).
In human RA synovial tissue the expression levels ofWnt1,Wnt5a and Fz5,Wnt7b [36, 37]
and of the wnt target geneWisp2 [38] were higher when compared with healthy adult tissue.
The same was true forWnt10a in human cartilage [36, 37].
Thus, we hypothesize that the dissimilar consequences of deletion of β-catenin in CD11c+
for the development of IBD, EAE and CIA might at least in part be explained by the local tissue
expression of wnt proteins and the DC-intrinsic gene machinery that lead to differential activa-
tion of wnt target genes in DCs present in each target tissue. To support this hypothesis we ana-
lyzed the expression of the wnt ligands not only in the synovium but also in the cortex. In the
cortex beside the presence of wnt2b, wnt5a, wnt5b and wnt9a, expressed in the synovial tissue,
wnt3, wnt7a, wnt8b were also expressed (Fig 9B) suggesting that the wnt signalling is more
prominent in this tissue than in the synovium. Moreover, no differences were found, in the
expression of the different wnt ligands, between the synovium isolated from control and β-catDEL
mice under the steady state (Fig 9A). In opposite, in the cortical tissue the mRNA expression of
wnt5a, wnt5b, wnt7a and wnt9a were reduced in β-catDEL compared to the control (Fig 9B).
In summary, we demonstrated that in the synovium only a few of the wnt ligand tested were
present and the expression levels of those did not differ between control and β-catDEL mice. In
contrast, most of the wnt ligands studied were present in the cortex and the expression of
wnt5a, wnt5b, wnt7a and wnt9a was reduced in the β-catDEL cortices. These data reinforce the
hypothesis that difference in phenotype observed in the different disease models can indeed, at
least in part, be explained by differences in the expression of wnt ligands in the target tissues.
Conclusions
In this study we demonstrated that: a) deletion of β-catenin in BMDCs did not influence their
activation, maturation profile or cytokine expression under steady state conditions and upon
in vitro activation with a TLR2 (MTB), TLR4 ligand (LPS) or collagen (CII); b) in the steady
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state, β-catenin deficiency in DCs did not affect the T cell homeostasis in vivo; c) loss of β-cate-
nin in DCs did not alter the onset, progression or severity of CIA; d) deletion of β-catenin in
CD11c+ cells resulted in a reduction of 20% in the percentage of splenic Tregs during CIA; e)
synovial expression of the wnt ligands: wnt2b, wnt5a, wnt5b and wnt9a.
Based on the published literature, we initially hypothesized that β-catenin plays a critical
role in the switch between the tolerogenic and immunogenic function of DCs and that the
Fig 9. Differential expression of wnt ligands in the synovium and cortex. Transcript levels measured by quantitative real time PCR in the synovial (A)
and cortical (B) tissues of control and β-catDEL mice under steady state condition. Wnt2b, wnt5a, wnt5b and wnt9a were expressed in both tissues, while
Wnt3, wnt7a, wnt8b were expressed in the cortical but not in synovial tissue. The expression of wnt5a (p = 0.0044), wnt5b (p = 0.0260), wnt7a (p = 0.0488)
and wnt9a (p = 0.0411) was lower in cortices of β-catDEL compared to control mice. N = 6 mice per group. Data are presented as mean ± SEM. Asterisks
indicate a significant difference compared with the control (Mann-Whitney U test). *p< 0.05; **p<0.01. N.d. Not detectable.
doi:10.1371/journal.pone.0142972.g009
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conditional deletion of β-cateninmight lead to exacerbated CIA and a pro-inflammatory cyto-
kine profile, with increased Th1 and Th17 cells and decreased Tregs. It has been shown that
DCs play a role in the initiation of arthritis (6) and might have therapeutic potential to treat
RA, since administration of semi-mature or tolerogenic DCs can inhibit CIA (7–9). In this
study, we observed a small decrease in Treg frequency in CIA β-catDEL mice, but we did not
find differences in the percentages of Th1 and Th17, nor in the pro-inflammatory cytokines
expressed by these cells. These data suggest that the β-catenin pathway in DCs is not a major
switch in the control of CIA. In contrast to CIA, in dextran sodium sulphate-induced IBD and
EAE the deletion of β-catenin in DCs led to an exacerbation of disease severity and an increase
in local inflammation [13–15]. On the other hand, activation of β-catenin signalling by stabili-
zation of the protein using a β-catenin agonist or by TLR2 stimulation seems to protect mice
from EAE [14, 15]. We hypothesize that the dissimilar consequences of deletion of β-catenin in
CD11c+ for the development of IBD, EAE and CIA might at least in part be explained by the
local tissue expression of wnt proteins and the DC-intrinsic gene machinery that lead to differ-
ential activation of wnt target genes in DCs present in each target tissue. In this study, we dem-
onstrated that wnt2b, wnt5a, wnt5b and wnt9a are expressed in the synovial tissue and no
differences were found between control and β-catDEL mice. However, in cortical tissue beside
those ligands also wnt3, wnt7a, wnt8b are present. Interestingly, in the cortex expression of
wnt5a, wnt5b, wnt7a and wnt9a was reduced in the β-catDEL cortices. These data suggest that
the differences in phenotype observed in the different disease models can, at least in part, be
explained by differences in the expression wnt ligands in the target tissues.
While further studies are needed to clarify this hypothesis, our findings highlight that β-
catenin signaling in DCs may not be the general ‘master switch’ of a tolerogenic DC phenotype
as it appears not capable to influence the course and severity of autoimmune arthritis.
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S1 Fig. Gating strategy to identify Th cell subsets based on their chemokine receptor pro-
file. Lymphocytes were gated according to their forward light scatter (FSC) and side light scat-
ter (SSC). Cell debris and doublets were excluded, and the cells were divided based on their
CD3 (BV785) expression. NK T cells were identified within the CD3- population based on
their NK1.1 (A700) expression. CD3+ cells were further divided into CD8+ (PE-Cy5) and
TCRδγ+ (BV605) cells and the double-negative population, containing mostly CD4+ T cells,
was further resolved based on CD4 (V500) and CD25 (PerCP-Cy5.5) expression.
CD25highCD4+ cells (Tregs) were excluded. The remaining population was gated (1) on
CXCR5 (FITC) and PD-1 (BV421) expression to identify Tfh or gated (2) on CD4 and CD62L
(APC-Cy7). Naïve CD62L+ T cells were excluded, and effector T cells (CD4+CD62L-) were fur-
ther divided based on their CCR6 (PE) expression. CCR6+ and CCR6- cells were further gated
based on their expression of CCR4 (APC) and CXCR3 (Pe-Cy7). From these, on the CCR6+
compartment we could identify: Th17 (CCR6+ CCR4+CXCR3-) and Th17.1 (CCR6+-
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